Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | EBSEmergent BioSolutions Inc.FY2025 · Dec |
|---|---|
| Revenue | $742.90M |
| Revenue, yoy | −28.8% |
| Net income | $52.60M |
| Net income, yoy | +127.6% |
| Net margin | 7.1% |
| Free cash flow | $156.80M |
| FCF margin | 21.1% |
| EPS, diluted | $0.93 |
Add another company.